Non-Polio enterovirus infections
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Enteroviruses are a genus of positive-sense single-stranded RNA viruses associated with several human and mammalian diseases. Serologic studies have distinguished 66 human enterovirus serotypes on the basis of antibody neutralization tests. Additional antigenic variants have been defined within several of the serotypes on the basis of reduced or nonreciprocal cross-neutralization between variant strains.
Classification
On the basis of their pathogenesis in humans and animals, the enteroviruses were originally classified into four groups, polioviruses, Coxsackie A viruses (CA), Coxsackie B viruses (CB), and echoviruses, but it was quickly realized that there were significant overlaps in the biological properties of viruses in the different groups. Enteroviruses isolated more recently are named with a system of consecutive numbers: EV68, EV69, EV70, and EV71, etc.[1].
Pathophysiology
Enteroviruses can be found in respiratory secretions (e.g., saliva, sputum, or nasal mucus) and stool of an infected person. Other persons may become infected by direct contact with secretions or stool from an infected person or by contact with contaminated surfaces or objects, such as a drinking glass or telephone. Parents, teachers, and child care center workers may also become infected by contamination of the hands with stool from an infected infant or toddler during diaper changes.
Causes
Non-polio enterovirus infections are caused by enteroviruses. Enteroviruses are a genus of positive-sense single-stranded RNA viruses associated with several human and mammalian diseases. Enteroviruses are made of ribonucleic acid (RNA) and protein. This group includes the polioviruses, coxsackieviruses, echoviruses, and other enteroviruses. In addition to the three different polioviruses, there are over 60 types of non-polio enteroviruses that can cause disease in humans. Non-polio enteroviruses are very common. They are second only to the “common cold” viruses, the rhinoviruses, as the most common viral infectious agents in humans.
Epidemiology and Demographics
Non-polio enteroviruses are very common. They are second only to the “common cold” viruses, the rhinoviruses, as the most common viral infectious agents in humans. The enteroviruses cause an estimated 10-15 million or more symptomatic infections a year in the United States. However, all three types of polioviruses have been eliminated from the Western Hemisphere, as well as Western Pacific and European regions, by the widespread use of vaccines.
Parents, teachers, and child care center workers may be prone to non-polio enterovirus infections as they can become infected by contamination of the hands with stool from an infected infant or toddler during diaper changes.
Risk Factors
Although everyone is at risk of infection, factors such as age and season can increase the chance of an individual getting infected by non-polio enteroviruses.
Diagnosis
History and Symptoms
Most people who are infected with a non-polio enterovirus have no disease at all. Infected persons who become ill usually develop either mild upper respiratory symptoms (a “summer cold”), a flu-like illness with fever and muscle aches, or an illness with rash.
References
Historical Perspective
Overview
The first documented outbreak of Acute hemorrhagic conjunctivitis due to ED-70 occurred in Ghana in 1969.EV D68, considered to be a pathogen exclusive to the respiratory tract for a long time, was first isolated in 1962 from four children in California suffering from pneumonia and bronchiolitis.CV-A24v was first isolated in 1970 in Singapore.
Historical Perspective
- The first documented outbreak of Acute hemorrhagic conjunctivitis due to ED-70 occurred in Ghana in 1969[1]. From 1970 and 1971, till the mid-1990s, the virus spread globally to produce the first AHC pandemic[2].
- Over the past decade, EV 71 has been implicated in many outbreaks of acute flaccid paralysis AFP in the Asia-Pacific region[3].
- In a systematic review evaluating surveillance data, case reports and case series of AFP, EV 71, echovirus 11 and echovirus 6 were reported more through surveillance while EV 71 and EV 68 were the predominant serotypes in case reports and case series[4].
- EV D68, considered to be a pathogen exclusive to the respiratory tract for a long time, was first isolated in 1962 from four children in California suffering from pneumonia and bronchiolitis[5]. Only sporadic cases were reported till the late 2000s with 26 between 1970 and 2005[6]. It caused the largest outbreak in 2014 in the USA, the first cases reported in August from Missouri and Illinois. Almost all the cases were children with a predominant history of asthma or wheezing[7].
- CV-A24v was first isolated in 1970 in Singapore[8] and remained restricted to South-East Asia and India until 1985, when it started causing widespread outbreaks.
References
- ↑ Chatterjee S, Quarcoopome CO, Apenteng A (1970). “Unusual type of epidemic conjunctivitis in Ghana”. Br J Ophthalmol. 54 (9): 628–30. doi:10.1136/bjo.54.9.628. PMC 1207974. PMID 5458256.
- ↑ Mirkovic RR, Kono R, Yin-Murphy M, Sohier R, Schmidt NJ, Melnick JL (1973). “Enterovirus type 70: the etiologic agent of pandemic acute haemorrhagic conjunctivitis”. Bull World Health Organ. 49 (4): 341–6. PMC 2480954. PMID 4368683.
- ↑ Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T (2010). “Clinical features, diagnosis, and management of enterovirus 71”. Lancet Neurol. 9 (11): 1097–105. doi:10.1016/S1474-4422(10)70209-X. PMID 20965438.
- ↑ Suresh S, Forgie S, Robinson J (2018). “Non-polio Enterovirus detection with acute flaccid paralysis: A systematic review”. J Med Virol. 90 (1): 3–7. doi:10.1002/jmv.24933. PMID 28857219.
- ↑ Schieble JH, Fox VL, Lennette EH (1967). “A probable new human picornavirus associated with respiratory diseases”. Am J Epidemiol. 85 (2): 297–310. doi:10.1093/oxfordjournals.aje.a120693. PMID 4960233.
- ↑ Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA, Centers for Disease Control and Prevention (2006). “Enterovirus surveillance–United States, 1970-2005”. MMWR Surveill Summ. 55 (8): 1–20. PMID 16971890.
- ↑ Midgley CM, Jackson MA, Selvarangan R, Turabelidze G, Obringer E, Johnson D; et al. (2014). “Severe respiratory illness associated with enterovirus D68 – Missouri and Illinois, 2014”. MMWR Morb Mortal Wkly Rep. 63 (36): 798–9. PMC 4584696. PMID 25211545.
- ↑ Mirkovic RR, Schmidt NJ, Yin-Murphy M, Melnick JL (1974). “Enterovirus etiology of the 1970 Singapore epidemic of acute conjunctivitis”. Intervirology. 4 (2): 119–27. doi:10.1159/000149850. PMID 4217326.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]
Overview
The genus Enterovirus belongs to the Picornaviridae family. It consists of 13 species of which seven contain human pathogens of more than 250 types, excluding three poliovirus serotypes. They include coxsackievirus, echovirus, numbered enterovirus and rhinovirus.
Classification[1]
- A6
- A10
- A16
Numbered enteroviruses
- A71
- B types
- A9
- A21
- A24
Numbered enteroviruses
- D68
- D70
References
- ↑ Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM (2018). “The life cycle of non-polio enteroviruses and how to target it”. Nat Rev Microbiol. 16 (6): 368–381. doi:10.1038/s41579-018-0005-4. PMID 29626210.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: {Sujaya}}
Overview
Enteroviral diseases are more likely to be severe in the immunocompromised, including patients with diabetes, HIV, neoplasms, or post-transplant status.The cellular uptake of enteorviruses is mediated by receptor molecules such as, intracellular adhesion molecule-1 (ICAM-1), low-density lipoprotein receptor (LDL-R), and non-protein factors such as heparan sulfate and sialic acid. Incubation periods range from 12 hours to 5 days, with experimental volunteers reporting symptoms several hours after aritficial inoculation.
- Replicate in the oropharyngeal mucosa and the intestines, leading to their detection in oral secretions and stool, the latter showing evidence of the pathogen months after resolution of the symptoms.
- Targets the lymphatic tissues such as the Peyer’s patches and the tonsils, paving the way for lymphatic and hematogenous dissemination
- Manifestations include myocarditis, pancreatitis and often a second, stronger viremia. This can cause serious clinical illness and facilitate direct crossing of the blood-brain barrier to affect the central nervous system.
- Alternative mechanisms include a “Trojan horse”entry model mediated by virus-infected leukocytes.
- Once present in the CNS, persistent infection is possible, likely by an immune response to the apoptosis and autophagy induced by this group of viruses.
- Exclusively affects the epithelial layer of the airways
- The mechanisms of uptake into cell include endocytosis and pinocytosis depending on the host and the virus type.
- On entry into the cell, the virion induces a conformational change by lowering the pH of the endosome or altering the receptor binding. This results in the exposure of hydrophobic domains and pore-mediated release of the viral particles into the cytoplasm of the genome, marking the beginning of viral polyprotein synthesis by the host cells.
- They do not participate in direct cell destruction, instead disrupting the epithelial barriers by stimulating Reactive oxygen species during their replication and dissociating zona occludens-1 from the tight junction complex. This triggers the release of cytokines, that activate granulocytes, monocytes and dendritic cells. IgG and IgA response takes about 1 to 2 weeks, usually after the virus has been eliminated but is crucial in preventing re-inoculation. Levels may remain high till a year after, but do not exhibit cross-reactivity among serotypes. On the contrary, viral load can indicate severity of the disease.
- In infants, rhinoviruses damage the respiratory cells and damage the immune response. They are an independent risk factor for the development of asthma and recurrent wheezing.
- In adults, they are the most common causes of acute exacerbations of COPD, necessitating hospital stays. They also contribute to abut two-thirds of viral upper respiratory tract infections-associated asthma exacerbations.
References
- ↑ Nikonov OS, Chernykh ES, Garber MB, Nikonova EY (2017). “Enteroviruses: Classification, Diseases They Cause, and Approaches to Development of Antiviral Drugs”. Biochemistry (Mosc). 82 (13): 1615–1631. doi:10.1134/S0006297917130041. PMC 7087576 Check
|pmc=value (help). PMID 29523062. - ↑ Royston L, Tapparel C (2016). “Rhinoviruses and Respiratory Enteroviruses: Not as Simple as ABC”. Viruses. 8 (1). doi:10.3390/v8010016. PMC 4728576. PMID 26761027.
- ↑ Huang HI, Shih SR (2015). “Neurotropic Enterovirus Infections in the Central Nervous System”. Viruses. 7 (11): 6051–66. doi:10.3390/v7112920. PMC 4664993. PMID 26610549.
- ↑ Jacobs SE, Lamson DM, St George K, Walsh TJ (2013). “Human rhinoviruses”. Clin Microbiol Rev. 26 (1): 135–62. doi:10.1128/CMR.00077-12. PMC 3553670. PMID 23297263.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]
Overview
Non-polio enterovirus infections are caused by a genus of positive-sense single-stranded RNA viruses associated with several human and mammalian diseases. Enteroviruses are made of ribonucleic acid (RNA) and protein. This group includes the coxsackieviruses, and echoviruses. Non-polio enteroviruses are very common. They are second only to the “common cold” viruses, the rhinoviruses, as the most common viral infectious agents in humans.
Causes[1]
- A6
- A10
- A16
Numbered enteroviruses
- A71
- B types
- A9
- A21
- A24
Numbered enteroviruses
- D68
- D70
References
- ↑ Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM (2018). “The life cycle of non-polio enteroviruses and how to target it”. Nat Rev Microbiol. 16 (6): 368–381. doi:10.1038/s41579-018-0005-4. PMID 29626210.
Differentiating Non-Polio enterovirus infections from other Diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]
Overview
The differential diagnoses of non-polio enterovirus infections spans diseases affecting the respiratory, gastrointestinal and central nervous systems:
- Influenza
- Adenovirus
- Upper respiratory tract infections (pharyngitis, sinusitis)
- Allergic rhinitis
- Meningitis
- Gastroenteritis
Differential diagnoses
Differential diagnoses for rhinovirus
Differential diagnoses of non-rhinovirus non-polio enterovirus infections
References
- ↑ “StatPearls”. 2022. PMID 29083802.
- ↑ Lynch JP, Kajon AE (2016). “Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention”. Semin Respir Crit Care Med. 37 (4): 586–602. doi:10.1055/s-0036-1584923. PMC 7171713 Check
|pmc=value (help). PMID 27486739. - ↑ Grief SN (2013). “Upper respiratory infections”. Prim Care. 40 (3): 757–70. doi:10.1016/j.pop.2013.06.004. PMC 7127764 Check
|pmc=value (help). PMID 23958368. - ↑ Varshney J, Varshney H (2015). “Allergic Rhinitis: an Overview”. Indian J Otolaryngol Head Neck Surg. 67 (2): 143–9. doi:10.1007/s12070-015-0828-5. PMC 4460099. PMID 26075169.
- ↑ Small P, Kim H (2011). “Allergic rhinitis”. Allergy Asthma Clin Immunol. 7 Suppl 1 (Suppl 1): S3. doi:10.1186/1710-1492-7-S1-S3. PMC 3245436. PMID 22166009.
- ↑ Small P, Kim H (2011). “Allergic rhinitis”. Allergy Asthma Clin Immunol. 7 Suppl 1 (Suppl 1): S3. doi:10.1186/1710-1492-7-S1-S3. PMC 3245436. PMID 22166009.
- ↑ Wheatley LM, Togias A (2015). “Clinical practice. Allergic rhinitis”. N Engl J Med. 372 (5): 456–63. doi:10.1056/NEJMcp1412282. PMC 4324099. PMID 25629743.
- ↑ Small P, Kim H (2011). “Allergic rhinitis”. Allergy Asthma Clin Immunol. 7 Suppl 1 (Suppl 1): S3. doi:10.1186/1710-1492-7-S1-S3. PMC 3245436. PMID 22166009.
- ↑ “StatPearls”. 2022. PMID 29083833.
- ↑ Graves NS (2013). “Acute gastroenteritis”. Prim Care. 40 (3): 727–41. doi:10.1016/j.pop.2013.05.006. PMC 7119329 Check
|pmc=value (help). PMID 23958366.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]
Overview
The long-term circulation dynamics are characterised by distinct epidemic and endemic patterns.Epidemics in temperate regions exhibit a characteristic seasonal variation, with peaks in summer and early autumn. This is less apparent in tropical regions. Climate, socio-economic factors and homotypic immunity likely contribute to the geographic distribution of different types. Enterovirus A sequences dominate in East and Southeast Asia while Enterovirus B is most common in Western Asia, Europe, Africa, South America, Southern Asia, and Oceania. Enteroviruses C and D are relatively rare.
The long-term circulation dynamics is characterised by distinct epidemic and endemic patterns[2].
- New types or strains can start off with a cryptic, endemic phase before assuming epidemic proportions (e.g. EV-A71[3], EV-D68[4])
- Bottlenecks from epidemic epidemiological cycles can limit diversity in certain areas, leading to a self-limiting pattern[5].
- Epidemics in temperate regions exhibit a characteristic seasonal variation, with peaks in summer and early autumn. This is less apparent in the tropical regions[6].
- Differences in geography can also change the timing of epidemic cycles, making them longer or even variable.
- The cause for the cyclical patterns is likely multifactorial, being a combination of weather, geographic barriers, hygiene, viral evolution, herd immunity, changes in the susceptible population and host factors.
- Homotypic immunity is probably the most important factor dictating transmission dynamics[6].
- The relative species prevalence also changes throughout the year[7].
Climate, socio-economic factors and homotypic immunity likely contribute to the geographic distribution of different types[8].
Sequences dominate in East (71%) and South-east Asia (73.4%), with the most common EV-A71, EV-A6, EV-A16, EV-A10 occurring in that order. Very low levels are detected in Africa, North America and Western Asia.
Most common in Western Asia(81.4%), Europe(63.1%), Africa(63%), South America(61.3%), Southern Asia(61%), Oceania (55.1%).
- A significant proportion exists in Africa(22.1%) and South America (21.2%); rarer in rest of the world
- CV-A 24 is the most commonly sequenced EV-C type, with higher proportion in South America
- Relatively rare worldwide; represent 76.7% of sequences in North America.
References
- ↑ 1.0 1.1 Brown DM, Zhang Y, Scheuermann RH (2020). “Epidemiology and Sequence-Based Evolutionary Analysis of Circulating Non-Polio Enteroviruses”. Microorganisms. 8 (12). doi:10.3390/microorganisms8121856. PMC 7759938 Check
|pmc=value (help). PMID 33255654 Check|pmid=value (help). - ↑ Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA, Centers for Disease Control and Prevention (2006). “Enterovirus surveillance–United States, 1970-2005”. MMWR Surveill Summ. 55 (8): 1–20. PMID 16971890.
- ↑ Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, Tong CY; et al. (2010). “Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene”. J Virol. 84 (7): 3339–50. doi:10.1128/JVI.01019-09. PMC 2838098. PMID 20089660.
- ↑ Tokarz R, Firth C, Madhi SA, Howie SRC, Wu W, Sall AA; et al. (2012). “Worldwide emergence of multiple clades of enterovirus 68”. J Gen Virol. 93 (Pt 9): 1952–1958. doi:10.1099/vir.0.043935-0. PMC 3542132. PMID 22694903.
- ↑ Yarmolskaya MS, Shumilina EY, Ivanova OE, Drexler JF, Lukashev AN (2015). “Molecular epidemiology of echoviruses 11 and 30 in Russia: different properties of genotypes within an enterovirus serotype”. Infect Genet Evol. 30: 244–248. doi:10.1016/j.meegid.2014.12.033. PMID 25562123.
- ↑ 6.0 6.1 Pons-Salort M, Oberste MS, Pallansch MA, Abedi GR, Takahashi S, Grenfell BT; et al. (2018). “The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers”. Proc Natl Acad Sci U S A. 115 (12): 3078–3083. doi:10.1073/pnas.1721159115. PMC 5866597. PMID 29507246.
- ↑ Brinkman NE, Fout GS, Keely SP (2017). “Retrospective Surveillance of Wastewater To Examine Seasonal Dynamics of Enterovirus Infections”. mSphere. 2 (3). doi:10.1128/mSphere.00099-17. PMC 5471348. PMID 28630939.
- ↑ Bo YC, Song C, Wang JF, Li XW (2014). “Using an autologistic regression model to identify spatial risk factors and spatial risk patterns of hand, foot and mouth disease (HFMD) in Mainland China”. BMC Public Health. 14: 358. doi:10.1186/1471-2458-14-358. PMC 4022446. PMID 24731248.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]
Overview
EV infections vary greatly in severity. Understanding the risk factors for severe infection may help clinicians identify infants at risk for adverse outcomes.
Risk Factors
Age[1]
- Prematurity
- Early age on onset of illness (<7 days of age)
- Higher WBC count: A higher degree of inflammation and consequent hepatic/myocardial damage
- Low hemoglobin: May signal a bleeding diathesis
Mothers infected shortly before delivery may pass the virus to the newborn. Babies born to mothers who have symptoms of enteroviral illness around the time of delivery are more likely to be infected.
Other factors[4]
- Low accessibility to water and high density and intimacy among family members due to small housing space [4.3m^2(1.10 m^2 per person)]: Apparent major reasons for high infectivity, although not statistically evident
- Sharing a kitchen and/or bathroom
- Inside toilet: Higher risk of intrafamilial spread
- Lack of cleaning of kitchen, bathroom, toilets and waste disposal areas
- Improper hand hygiene
References
- ↑ 1.0 1.1 Lin TY, Kao HT, Hsieh SH, Huang YC, Chiu CH, Chou YH; et al. (2003). “Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections”. Pediatr Infect Dis J. 22 (10): 889–94. doi:10.1097/01.inf.0000091294.63706.f3. PMID 14551490.
- ↑ Modlin JF (1986). “Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries”. Rev Infect Dis. 8 (6): 918–26. doi:10.1093/clinids/8.6.918. PMID 3541126.
- ↑ Abzug MJ (2001). “Prognosis for neonates with enterovirus hepatitis and coagulopathy”. Pediatr Infect Dis J. 20 (8): 758–63. doi:10.1097/00006454-200108000-00008. PMID 11734737.
- ↑ Kuramitsu M, Kuroiwa C, Yoshida H, Miyoshi M, Okumura J, Shimizu H; et al. (2005). “Non-polio enterovirus isolation among families in Ulaanbaatar and Tov province, Mongolia: prevalence, intrafamilial spread, and risk factors for infection”. Epidemiol Infect. 133 (6): 1131–42. doi:10.1017/S0950268805004139. PMC 2870349. PMID 16274512.
Natural History, Complications and Prognosis
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
External Links
External Links
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
